OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Psychiatry is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	853
Error in Results	642
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	471
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	400
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	366
Assumptions and Limitations of the Synthetic Control Method	335
Diagnosing and Treating ADHD in Adults	320
An Opportunity to Advance Cannabis Science—DEA Rescheduling	266
Managerial and Organizational Challenges in the Age of AI	229
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	221
Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression	215
The Reliability of Traumatic and Adverse Experiences	187
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	179
Potential Lessons for DSM From Contemporary Philosophy of Science	177
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	172
Healing Ethno-Racial Trauma in Black Communities	168
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	167
Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA	165
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	164
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	149
Moving Beyond Medications That Act at the μ Receptor in the Treatment of Opioid Use Disorder	148
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	143
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	141
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	135
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	128

Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	122
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	120
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	117
Error in Byline	116
Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness	114
JAMA Psychiatry	114
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	112
JAMA Network Call for Papers on Health and the 2024 US Election	110
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	110
Hyperalgesia in Patients With a History of Opioid Use Disorder	108
Errors in Figures 1 and 2	108
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	108
Living Alone and Drug Overdose Deaths in the US	108
JAMA Psychiatry	103
Addiction Medicine Physicians and Medicinal Cannabinoids	101
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	101
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	96
Searching the Brain for the Cause of Psychosis	96
Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction	95
Perinatal Mental Health Outcomes Following Natural Disasters	93
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic	92
Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression	92
Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth	91
Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis	89
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	87
JAMA Psychiatry	85
COVID-19 and Mental Health in Young People—Causality or Co-occurrence?	84
JAMA Psychiatry—The Year in Review, 2021	84
Etiologic Studies of Premenstrual Disorders Require Prospective Confirmation of Affective Cyclicity	82
Associating Violence With Schizophrenia—Risks and Biases—Reply	82
JAMA Psychiatry	81
Errors in Figures 3, 4, and 5	79
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression	78
Trends in Outpatient Psychotherapy Among Adults in the US	77
Expanding Current Approaches to Solve the Opioid Crisis	77
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	76
Evaluation of a Model to Target High-risk Psychiatric Inpatients for an Intensive Postdischarge Suicide Prevention Intervention	76
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study	76
Limitations for Assessing Optimism and Physical Functioning in Women—Reply	74
Implementation Strategies Used and Reported in Brief Suicide Prevention Intervention Studies	73
JAMA Psychiatry	72
New Directions in Research on Heterogeneity of Treatment Effects for Major Depression	70
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation	69
Does Vaccination Really Mitigate Psychiatric Implications of COVID-19?—Reply	69
Adjuvant Psychotherapies to Prevent Relapse in Bipolar Disorder	69